Published in
American Society of Nephrology, Clinical Journal of the American Society of Nephrology, 11(6), p. 2620-2627, 2011
DOI: 10.2215/cjn.06970711
Links
- ORCID
- ORCID
- American Society of Nephrology
- [www.ncbi.nlm.nih.gov] | PDF
- [hdl.handle.net]
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Sympathetic Nerve Traffic and Asymmetric Dimethylarginine in Chronic Kidney Disease
Journal article published in 2011 by
Guido Grassi,
Gino Seravalle 
,
Lorenzo Ghiadoni,
Giovanni Tripepi,
Rosa Maria Bruno ,
Giuseppe Mancia,
Carmine Zoccali
,
Lorenzo Ghiadoni,
Giovanni Tripepi,
Rosa Maria Bruno ,
Giuseppe Mancia,
Carmine Zoccali
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Sympathetic overactivity and high levels of the endogenous inhibitor of NO synthase asymmetric dimethylarginine (ADMA) are prevalent risk factors in chronic kidney disease (CKD).